POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER).

How it works

Potassium is the major intracellular cation; it maintains intracellular tonicity, is essential for nerve impulse transmission, cardiac contraction, and skeletal muscle function. Dextrose provides metabolic energy. Lactated Ringer's solution replaces extracellular fluid and electrolytes.

What the body does with it

Metabolism	Potassium is primarily eliminated renally; dextrose undergoes glycolysis and oxidative metabolism; lactate is converted to bicarbonate in the liver.
Excretion	Renal: >90% as potassium ions; minimal biliary/fecal elimination.
Half-life	Not applicable; potassium is an electrolyte with no classical half-life. Serum potassium regulation depends on redistribution (t1/2 ~1-2 hours) and renal excretion (rate varies with GFR).
Protein binding	Not significantly protein-bound (<2%).
Volume of Distribution	0.5-0.7 L/kg; distributes primarily in extracellular fluid.
Bioavailability	Intravenous: 100%.
Onset of Action	Intravenous: Immediate (minutes) for serum potassium elevation.
Duration of Action	Intravenous: 2-4 hours for acute effect; continuous infusion maintains steady state.

Classification & Brands

Dosing & administration

Adult: 10-20 mEq/h IV, not exceeding 30 mEq/h or 200 mEq/day; rate determined by serum potassium and ECG monitoring. Maximum concentration 40 mEq/L in peripheral line, 100 mEq/L in central line.

Dosage form	INJECTABLE
Renal impairment	GFR 30-50 mL/min: reduce dose by 50% or use with caution; GFR <30 mL/min: avoid use due to risk of hyperkalemia; use only if potassium deficit documented and serum K+ monitored frequently.
Liver impairment	Child-Pugh A: no adjustment; Child-Pugh B or C: no specific adjustment but monitor serum potassium and acid-base status due to potential for concurrent metabolic alkalosis.
Pediatric use	Neonates and children: 0.5-1 mEq/kg/dose IV, maximum 30 mEq/dose; infuse at rate not exceeding 0.3 mEq/kg/h; must be diluted to concentration ≤40 mEq/L for peripheral IV.
Geriatric use	Elderly patients: start at low end of dosing range (10 mEq/h); monitor renal function and serum potassium frequently due to age-related decline in GFR and increased risk of hyperkalemia.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Breastfeeding	Potassium chloride, dextrose, and lactated Ringer's components are normal plasma constituents. No specific M/P ratio available; considered safe during breastfeeding. Monitor infant for electrolyte disturbances if high doses used.
Teratogenic Risk	No evidence of teratogenicity from potassium chloride. Dextrose and lactated Ringer's components are essential nutrients; no malformation risk at therapeutic doses. Overdose or hyperkalemia may cause fetal arrhythmia or death.

Warnings & precautions

■ FDA Black Box Warning

Potassium chloride injections should be administered only in patients with normal renal function and in the presence of adequate urine flow, as hyperkalemia can occur and may be fatal.

Side Effect Profile

Serious Effects

Absolute Contraindications

["Hyperkalemia","Renal failure with oliguria or anuria","Addison's disease","Concomitant use with potassium-sparing diuretics","Severe metabolic acidosis","Acute dehydration"]

Clinical Precautions

Precautions

["Use with caution in patients with cardiac disease, renal impairment, or conditions predisposing to hyperkalemia","Monitor serum potassium levels and ECG during administration","Do not use if solution is cloudy or contains precipitate","Dextrose solutions may cause hyperglycemia; use with caution in diabetes mellitus"]

Clinical Tips & Counseling

Drug interactions

Loading safety data…